An example of this is HL2401, a monoclonal antibody anti-CXCL1 [38], which inhibits the proliferation and migration of bladder cancer cells, as well as bladder cancer tumor growth in an in vivo model. Here, CXCL1 is linked to urinary bladder carcinoma.